Search

everythinglearnresearchcommunity

for

Search:↓

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women with PCOS should have an oral glucose tolerance test for effective diabetes screening.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

Glycated hemoglobin is not as effective as the oral glucose tolerance test for diagnosing blood sugar problems in women with PCOS in Southern Iraq.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Herbal treatments can help manage PCOS symptoms.

High testosterone increases heart disease risk in women with PCOS.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Melatonin may help treat PCOS symptoms in rats.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.